A sharp increase in the incidence of pediatric thyroid papillary cancer was documented after the Chernobyl power plant explosion. An increased prevalence of rearrangements of the RET protooncogene (RET/PTC rearrangements) has been reported in Belarussian postChernobyl papillary carcinomas arising between 1990 and 1995. We analyzed 67 post-Chernobyl pediatric papillary carcinomas arising in 1995-1997 for RET/PTC activation: 28 were from Ukraine and 39 were from Belarus. The study, conducted by a combined immunohistochemistry and RT-PCR approach, demonstrated a high frequency (60.7% of the Ukrainian and 51.3% of the Belarussian cases) of RET/ PTC activation. A strong correlation was observed between the solidfollicular subtype of papillary carcinoma and the RET/PTC3 isoform: 19 of the 24 RET/PTC-positive solid-follicular carcinomas harbored a RET/PTC3 rearrangement, whereas only 5 had a RET/PTC1 rearrangement. Taken together these results support the concept that RET/PTC activation plays a central role in the pathogenesis of thyroid papillary carcinomas in both Ukraine and Belarus after the Chernobyl accident. (J Clin Endocrinol Metab 84: 4232-4238, 1999) 
T HYROID CANCER is the most common form of solid neoplasm associated with radiation exposure (1) . A relationship between therapeutic irradiation and development of thyroid carcinoma was proposed in 1950 (2) and subsequently confirmed in other studies (3) . Survivors exposed to external radiation from the atomic bombs in Japan (4) and inhabitants of the Marshall Islands, exposed to radioiodines after the testing of a thermonuclear device (5), showed an increased incidence of papillary thyroid carcinomas. The meltdown of the Chernobyl reactor (April 26, 1986 ) was estimated to have released 8 ϫ 10
18 becquerels of radiation (6) . After this disaster, childhood thyroid carcinoma showed a great increase (up to a 100-fold) in Belarus, Ukraine, and western regions of Russia (7) (8) (9) (10) (11) (12) .
Gene rearrangements generating the chimeric RET/PTC oncogenes are found in thyroid papillary carcinomas (13) (14) (15) (16) (17) (18) (19) . These rearrangements cause the fusion of RET to heterologous genes. RET encodes the tyrosine kinase receptor for growth factors of the GDNF family (20) . The oncogene resulting from the fusion of RET to the H4 gene has been designated RET/PTC1 (14) . RET/PTC2 and RET/PTC3 are generated by the fusion between RET and the gene for the RI␣ subunit of protein kinase A or the RFG (also named ELE1) gene (21) (22) (23) , respectively. Finally, RET/PTC5 is the fusion between RET and the RFG5 gene (24) . A paracentric inversion of the long arm of chromosome 10 is responsible for the generation of RET/PTC1 and RET/PTC3, whereas RET/PTC2 is generated by a reciprocal balanced translocation (25) . RET/PTC rearrangements are restricted to thyroid carcinomas of the papillary histotype (15, 18) . They are found with a high frequency in clinically silent, small papillary carcinomas; this suggests that they can be early events in the tumorigenesis process (18, 19, 26) . Mice transgenic for RET/ PTC oncogenes develop papillary thyroid carcinomas (27) (28) (29) . Moreover, both RET/PTC1 and RET/PTC3 (30) (34) .
Although a strong increase in the incidence of childhood thyroid papillary carcinomas was observed in Ukraine after the nuclear accident (35) , RET/PTC activation has not been previously studied in Ukrainian samples. We have analyzed post-Chernobyl pediatric papillary carcinomas from Ukraine and Belarus for RET/PTC activation. The results indicate that a high frequency of RET/PTC activation is a feature of both Belarussian and Ukrainian cases. Moreover, in both series a strong correlation between the solid-follicular carcinoma and activation of the RET/PTC3 oncogene was observed.
Materials and Methods Patients
Twenty-eight thyroid papillary carcinomas from Ukraine and 39 from Belarus that occurred in patients living in areas contaminated by the Chernobyl nuclear accident and that were operated between January 1995 and July 1997 were studied. Seven follicular carcinomas and 9 follicular adenomas from Ukraine were also studied. The age of the patients ranged between 6 -18 yr; 18 patients were male, and 49 were female. The morphological and epidemiological features of these tumors will be described elsewhere (Thomas, G., et al., manuscript in preparation). Histological slides stained by hematoxylin-eosin were reviewed by at least two pathologists from Cambridge and either Minsk or Kiev. Overall classification was performed according to the WHO recommendations (1, 36) .
Immunohistochemistry
Five-to 6-m paraffin sections were deparaffinized, placed in a solution of absolute methanol and 0.3% hydrogen peroxide for 30 min, and then treated with blocking serum for 20 min. The slides were incubated with affinity-purified polyclonal antibodies specific for the RET tyrosine kinase domain (18, 26) (1:100) and with biotinylated antirabbit IgG (Vectostain ABC kits, Vector Laboratories, Inc., Burlingame, CA) and with premixed reagent ABC (Vector Laboratories, Inc.). Immunostaining was performed with a diaminobenzidine (DAKO Corp., Carpinteria, CA) solution (0.06 mmol/L diaminobenzidine and 2 mmol/L hydrogen peroxide). The slides were counterstained with hematoxylin.
RT-PCR for RET/PTC expression
Ribonucleic acid (RNA) extraction, RT, and subsequent PCR amplification were performed as previously reported (26) . Positive controls were represented by tumor samples harboring RET/PTC1, RET/PTC2, or RET/PTC3 rearrangements (18) . Forward primers were: RET/PTC1, 5Ј-ATTGTCATCTCGCCGTTC-3Ј (nucleotides 196 -214) (14) ; RET/ PTC2, 5Ј-TATCGCAGGAGAGACTGTGAT-3Ј (nucleotides 483-503) (21) ; and RET/PTC3, 5Ј-AAGCAAACCTGCCAGTGG-3Ј (nucleotides 697-714) (22) . Another RFG primer (5Ј-AACTGTCCTGCTCTTTGA-3Ј, nucleotides 481-498) was used to detect alternative types of RET/PTC3 (RET/PTC3r2) rearrangements (37) . The primer 5Ј-TACTAGAATACT-GCAATC-3Ј was used to detect the RFG5-RET (RET/PTC5) rearrangement (24) . The sequence of the common reverse primer (on the RET tyrosine kinase sequence) was 5Ј-TGCTTCAGGACGTTGAAC-3Ј (nucleotides 543-561) (14) . Five hundred nanograms of RNA were reverse transcribed and subjected to 40 cycles of PCR (Perkin-Elmer Corp., Norwalk, CT; 94 C for 30 sec, 55 C for 2 min, and 72 C for 2 min). The product was analyzed on a 2% agarose gel and hybridized with a RET probe covering the tyrosine kinase domain. The human hypoxanthine phosphoribosyltransferase-specific primers were 5Ј-CCTGCTGGATTA-CATCAAAGCACTG-3Ј (nucleotides 316 -340) and 5Ј-CCTGAAGTAT-TCATTATAGTCTCAAGG-3Ј (nucleotides 685-661) (38) . Nine of the RET/PTC1-positive and eight of the RET/PTC3-positive amplified products were completely sequenced to confirm the rearrangement (Sequenase, U.S. Biochemical Corp., Cleveland, OH).
Statistical analysis
The association between the RET/PTC3 rearrangement and the solidfollicular variant was analyzed by the 2 test.
Results
Papillary thyroid carcinomas from Ukraine and Belarus have been analyzed for RET/PTC activation by RT-PCR, using one primer on RET exon 12 and forward primers mapping on the H4, RIa, and RFG genes. The PCR products were subjected to Southern blotting with a probe spanning the RET kinase domain. The quality of the samples was assessed by amplifying the human hypoxanthine phosphoribosyltransferase messenger RNA. The results summarized in Table 1 and shown in Fig. 1 demonstrated a high prevalence of RET rearrangements. The prevalence of RET/PTC-positive cases was slightly higher in the Ukrainian (60.7%) than in the Belarussian (51.3%) series. No case of RET/PTC2 rearrangement was observed; 23 samples were positive for RET/PTC3, and 14 were positive for RET/PTC1. Sixteen follicular neoplasms from Ukraine scored negative (Table 1) .
Papillary thyroid carcinomas occurred in children after the Chernobyl disaster have been divided classic, solid-follicular, and diffuse-sclerosing subtypes. A high prevalence of the solid-follicular tumors among them has been reported (39). Table 2 shows that a correlation (P Ͻ 0.01) between the solid-follicular histotype and the type of RET/PTC rearrangement was observed; 41% of the solid-follicular carcinomas were positive for RET/PTC3, whereas only 10% of them were RET/PTC1 positive. Conversely, a large portion (41%) of the carcinomas of the classic type were RET/PTC1 positive. Interestingly, in the case of one Ukrainian solidfollicular carcinoma (not included in the tables), both RET/ PTC1 and RET/PTC3 rearrangements were detected ( Fig. 1 , sample 2); this suggests that more than one independent neoplastic clone was present in the same gland. Diffusesclerosing carcinomas (four cases) were present only in the Ukraine series. Intriguingly, a high proportion of them (three of four) were RET/PTC positive (two RET/PTC1 and one RET/PTC3; Table 2 ). The analysis of a higher number of samples will be required to assess whether this papillary (Table 3 and Fig. 2 ). Lymph node metastasis specimens were available for eight Ukrainian patients; the primary tumor scored positive for RET rearrangement in five and negative in three. In all cases in which the primary tumor was positive, the metastasis also scored positive and showed the same type of RET/PTC rearrangement; two representative examples are shown in Fig. 2 . In two cases, two independent metastases were available from the same patient, and both showed the presence of the same rearrangement (Table 3) . Interestingly, one of the three metastatic lesions derived from patients whose primary tumor was negative for RET activation showed the presence of a RET/PTC3 rearrangement; the patient had a solid-follicular carcinoma (Fig. 2 , lane 4, and Table 3 ). It is possible that the rearrangement occurred during the metastatic dissemination or, alternatively, that it was already present, but in only a minority of the cells of the primary tumor. RET/PTC3 rearrangements have been described in which a shorter portion of the RFG gene is fused to RET (RET/ PTC3r2 and RET/PTC3r3) (37) . Because RET/PTC3r2 could not be detected by the primer pair used here, samples scored negative at the first analysis were subjected to RT-PCR using a second RFG primer mapping upstream from the alternative breakpoint. Moreover, a rearrangement between RET and the RFG5 gene, RET/PTC5, has been described in two postChernobyl Belarussian samples (24); 15 of the 30 negative samples were analyzed for the RET/PTC5 rearrangement. No alternative RET/PTC3 and no RET/PTC5 rearrangements were found in our series (data not shown). However, we cannot exclude that alternative rearrangements, for which an adequate RT-PCR assay is not yet available, are present in Chernobyl carcinomas. For instance, while this manuscript was in preparation, another RET/PTC variant has been reported in which RET is fused to a novel gene (ELKS) mapping on chromosome 12 (40) . It would be interesting to verify the presence of this rearrangement in postChernobyl tumors.
To confirm the presence of a RET rearrangement and to demonstrate the expression of the rearranged RET product, the 17 Ukrainian samples that were RET/PTC positive in the RT-PCR and the 19 negative Ukrainian samples (4 classic and 6 solid-follicular papillary carcinomas and 9 adenomas) were analyzed by immunohistochemistry with anti-RET antibodies. RET expression is not normally found in follicular cells a There is a significant association between the solid-follicular subtype and the presence of RET/PTC3 rearrangement by 2 test, P Ͻ 0.01).
(41); after the rearrangements, RET transcriptional regulatory sequences are replaced by those belonging to the fused genes, and this causes RET/PTC expression (18, 26) . A good correlation was found between RET/PTC rearrangement detected by RT-PCR and RET protein expression. All 17 positive samples showed an intense immunostaining with the anti-RET antibodies. Representative examples of immunostaining of classic and solid-follicular papillary carcinomas are shown in Fig. 3 . When the primary tumor was positive for RET/PTC protein expression, the metastatic lesion (5 cases) was positive also (1 representative example is shown in Fig. 4B ). In some cases the anti-RET antibody was able to detect the presence of a neoplastic embolus in the infiltrated vessels of the thyroid tumor (Fig. 4A) . The 9 follicular adenomas were negative on immunohistochemistry. As a negative control, 10 samples of normal thyroid tissue were analyzed and invariably scored negative. One of the 10 papillary carcinomas that were negative at the RT-PCR showed a focal positivity on immunohistochemistry (not shown); it is possible that only a few neoplastic cells carried the rearrangement in that case and/or that RET rearrangements other than those detectable with the primer pairs used were present.
Discussion
This study shows that thyroid papillary carcinomas arising in children from Ukraine and Belarus, who had been exposed to high levels of fallout radiation from Chernobyl, have a high proportion of RET rearrangements. Our unpublished immunohistochemical observations on an additional set of 50 post-Chernobyl thyroid cancers confirmed the high frequency of RET activation (Chiappetta, G., et al., unpublished results). Several studies on small numbers of cases from Belarus have also found a high proportion with RET rearrangement (31) (32) (33) . One previous study showed an even higher proportion of tumors positive for RET rearrangement (77%) than we have found (34) . These cases occurred before 1992, whereas our study examined cases from 1995-1997; the possibility that, after the Chernobyl disaster, papillary carcinomas arose earlier and had an increased prevalence of RET/PTC positivity, because the occurrence of a RET rearrangement shortens the latency period of the carcinomas, has to be taken into consideration.
Together, these studies show that post-Chernobyl tumors have a high frequency of RET activation; this frequency has continued from the early years after the accident up to the present. The frequency of RET/PTC activation in nonexposed adult populations has been reported to vary from 2.5-40% in different series (13) (14) (15) (16) (17) (18) (19) . These differences have been ascribed at least in part to the geographic origin of the patients studied. In one recent report the age of the patients has also been demonstrated to be an important factor, as thyroid carcinomas in patients under 30 yr of age, lacking evidence of exposure to radiation, showed a higher frequency of RET/PTC activation than older patients (42) . Thus, a matched control (age and region) would be necessary to ascertain whether the exposure to radioactive isotopes has really caused an increase in the prevalence of RET rearrangements. For a number of reasons, including the extreme rarity of thyroid carcinomas in children in the Chernobyl area before the accident (0.5 cases/million⅐yr) (12) , such a control is very difficult to obtain. However, several considerations support the idea of the important role played by RET rearrangements in radiation-associated thyroid papillary carcinomas. The prevalence of RET/PTC activation in post-Chernobyl carcinomas [in our study and the other published reports (31) (32) (33) (34) ] is higher than the highest frequencies reported in the literature in nonexposed subjects. Moreover, mutations of other genes (ras, G s ␣ TSHR, and p53) known to be involved in thyroid carcinogenesis have not been detected or have occurred at a very low prevalence in post-Chernobyl tumors (43, 44) (Santoro, M., et al., submitted) . In addition, the fact that ionizing radiation can induce RET/PTC rearrangement in vitro (45, 46) and the high frequency of RET/ PTC rearrangements in patients exposed to external radiation (47) support the hypothesis that these rearrangements can be a direct consequence of radiation exposure.
One of the most striking features of post-Chernobyl papillary carcinomas is the correlation between the type of rearrangement and the morphological variant of the carcinoma. Frequently, post-Chernobyl carcinomas have a solidfollicular aspect (46 of 67 cases in the present series). This variant is characterized by solid nests of tumor cells, often with many small follicular lumina; it may also show a minor papillary component and tumor cells with ground-glass nuclei and nuclear grooves typical of papillary carcinomas (39, 48) . Although we have found RET/PTC1 favored in tumors having a prevalent classic aspect (7 of 10 RET/PTC-positive samples), a prevalence of the RET/PTC3 isoform (19 of 24 RET/PTC-positive samples) was observed in papillary carcinomas of the solid-follicular type. This is intriguing, because this morphological variant is rarely found in the nonexposed population, and it is considered by some researchers Then the slides were incubated with affinity-purified antibodies specific for the RET tyrosine kinase domain and subsequently with biotinylated goat antirabbit IgG. Immunostaining was performed with diaminobenzidine. After chromogen development, the slides were counterstained with hematoxylin. Representative examples are shown. A, Normal thyroid tissue. B, Thyroid papillary carcinoma of a patient scored negative for RET rearrangement; no staining is observed. C, Thyroid papillary carcinoma, classic variant, of a patient scored positive for RET/PTC1 rearrangement; intense staining is observed in the neoplastic cells. D, Thyroid papillary carcinoma, solid-follicular variant, of a patient scored positive for RET/PTC3 rearrangement; intense staining is observed in the neoplastic cells. In all positive cases the signal was efficiently displaced by a molar excess of the antigen and was not detected when the primary antibody was omitted (data not shown). Magnification, ϫ300.
as evidence of a more malignant phenotype (49); consistently, post-Chernobyl carcinomas are relatively aggressive, showing intraglandular dissemination, extension to the perithyroid tissue, and distant metastases. This correlation, described first by Nikiforov et al. (34) , has been confirmed experimentally in transgenic mouse models. Although the targeted expression of RET/PTC1 to the thyroid gland caused the generation of carcinomas of the classic type (27, 28) , RET/PTC3 mice develop aggressive carcinomas with a prevalent solid component, which are highly prone to metastasize to regional lymph nodes (29) . It is still unknown which difference(s) between the two oncoproteins explains their different effects in vivo. The RET component of the 2 chimeric proteins is identical, and our recent findings indicate that there is no significant difference in the extent of activation of the intrinsic RET kinase function in RET/PTC1 and RET/PTC3 (Melillo, R. M., et al., unpublished observations). Thus, although the function of H4 and RFG genes (in the case of RET/PTC1 and RET/PTC3, respectively) is still unknown, it is tempting to speculate that some functional differences between the two RET fusion partners may contribute to the different neoplastic phenotypes.
We conclude that a high proportion of post-Chernobyl thyroid carcinomas in children show RET rearrangement, and that there are good reasons to believe that there is a causal link between radiation exposure and the rearrangement. We also find a strong correlation between the morphological subtype of papillary carcinoma and the type of RET rearrangement; this link is seen in both humans and transgenic animals. RET/PTC3 rearrangement is particularly prevalent in radiation-induced tumors in children, but whether this is linked primarily to the nature of the carcinogenic agent or to the age of the child remains to be determined. For more information, please write: Dr. G. Copinschi, Laboratory of Experimental Medicine, Brussels Free University-CP 618, 808 Route de Lennik, B-1070 Brussels, Belgium.
